Linked e-resources
Details
Table of Contents
Intro; Foreword; Preface; Contents; About the Editors; 1: Aging Principles and Perspectives for Intervention; 1.1 Introduction; 1.2 Basis of Survival: Homeostasis Versus Homeodynamics; 1.3 Genetics and Epigenetics of Aging; 1.4 Molecular Mechanisms of Aging; 1.5 Aging Interventions: Treatment, Prevention or Management; 1.5.1 Piecemeal Remedies; 1.5.2 Replenishment and Supplementation; 1.5.3 Strengthening the Homeodynamics; 1.5.4 Gene Therapy and Intelligent Redesigning; 1.6 Recapitulation; References
2: Non-coding RNAs as Potential Targets for Treatment and Early Diagnosis of Age-Associated Neurodegenerative Diseases2.1 Introduction; 2.2 Neurodegenerative Diseases; 2.2.1 Alzheimer's Disease; 2.2.2 Parkinson's Disease; 2.3 Challenges in Treating the Neurodegenerative Diseases; 2.4 Treatments Available; 2.5 Junk DNA Hypothesis; 2.6 Non-coding RNAs; 2.7 History of miRNA; 2.8 Role of Non-coding RNAs in Various Disease Progressions; 2.9 Non-coding RNAs and Alzheimer's Disease; 2.10 Non-coding RNAs and Parkinson's Disease; 2.11 Non-coding RNAs and Huntington's Disease
2.12 Non-coding RNAs and Amyotrophic Lateral Sclerosis (ALS)2.13 miRNAs and circRNAs as Potential Targets for Neurodegenerative Diseases; 2.14 Progress Being Made; 2.15 Strategies Ahead; 2.16 Advent of Non-coding RNAs as an Early Diagnostic Tool; 2.17 C. elegans as Model Organism to Study the Role of Non-coding RNAs for Neurodegenerative Diseases; 2.18 Future Directions; References; 3: The Potential Role of Stem Cell Reprogramming in Antiaging; 3.1 Stem Cells and Aging; 3.2 Recent Advances in Cellular Reprogramming Era; 3.3 Molecular Mechanism of Stem Cell Reprogramming
3.4 Antiaging Strategy with In Vivo and In Vitro Stem Cell Reprogramming3.5 Therapeutic Approaches of Aging; 3.6 Conclusion; References; 4: Tissue Engineering and Regenerative Medicine: A Translational Research for Antiaging Strategy; 4.1 Introduction; 4.2 Stem Cells, Sources, and Its Therapeutic Potential; 4.3 Tissue Engineering for Aging-Associated Disorder; 4.4 Biomaterials; 4.5 Tissue Engineering Strategies for Aging-Associated Liver Disorders; 4.6 Tissue Engineering Strategies for Aging-Associated Cardiovascular Disorders
2: Non-coding RNAs as Potential Targets for Treatment and Early Diagnosis of Age-Associated Neurodegenerative Diseases2.1 Introduction; 2.2 Neurodegenerative Diseases; 2.2.1 Alzheimer's Disease; 2.2.2 Parkinson's Disease; 2.3 Challenges in Treating the Neurodegenerative Diseases; 2.4 Treatments Available; 2.5 Junk DNA Hypothesis; 2.6 Non-coding RNAs; 2.7 History of miRNA; 2.8 Role of Non-coding RNAs in Various Disease Progressions; 2.9 Non-coding RNAs and Alzheimer's Disease; 2.10 Non-coding RNAs and Parkinson's Disease; 2.11 Non-coding RNAs and Huntington's Disease
2.12 Non-coding RNAs and Amyotrophic Lateral Sclerosis (ALS)2.13 miRNAs and circRNAs as Potential Targets for Neurodegenerative Diseases; 2.14 Progress Being Made; 2.15 Strategies Ahead; 2.16 Advent of Non-coding RNAs as an Early Diagnostic Tool; 2.17 C. elegans as Model Organism to Study the Role of Non-coding RNAs for Neurodegenerative Diseases; 2.18 Future Directions; References; 3: The Potential Role of Stem Cell Reprogramming in Antiaging; 3.1 Stem Cells and Aging; 3.2 Recent Advances in Cellular Reprogramming Era; 3.3 Molecular Mechanism of Stem Cell Reprogramming
3.4 Antiaging Strategy with In Vivo and In Vitro Stem Cell Reprogramming3.5 Therapeutic Approaches of Aging; 3.6 Conclusion; References; 4: Tissue Engineering and Regenerative Medicine: A Translational Research for Antiaging Strategy; 4.1 Introduction; 4.2 Stem Cells, Sources, and Its Therapeutic Potential; 4.3 Tissue Engineering for Aging-Associated Disorder; 4.4 Biomaterials; 4.5 Tissue Engineering Strategies for Aging-Associated Liver Disorders; 4.6 Tissue Engineering Strategies for Aging-Associated Cardiovascular Disorders